Pathogenesis of chronic obstructive pulmonary disease (COPD)

Clinical and Applied Immunology Reviews

Volumn 5, Issue 5, 2005, Pages 339-351

  Daheshia, Massoud ^a  

^a LOVELACE RESPIRATORY RESEARCH INSTITUTE   (United States)

Author keywords

Asthma; COPD; Epithelium; Exacerbation; Inflammation; Lung

Indexed keywords

CIGARETTE SMOKE; CYTOKINE; FLUTICASONE PROPIONATE; PROTEINASE; STEROID; TOXIC GAS;

AIRWAY OBSTRUCTION; ASTHMA; BACTERIAL INFECTION; CELL INTERACTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; DEATH; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE EXACERBATION; ENVIRONMENTAL EXPOSURE; EXTRACELLULAR MATRIX; HUMAN; INFLAMMATORY CELL; LUNG ALVEOLUS; LUNG INSUFFICIENCY; LUNG PARENCHYMA; MACROPHAGE; MUCUS SECRETION; NEUTROPHIL; OXIDATIVE STRESS; PARTICULATE MATTER; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM; RESPIRATORY TRACT INFLAMMATION; REVIEW; RISK FACTOR; T LYMPHOCYTE;

EID: 29944433420     PISSN: 15291049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cair.2005.09.003     Document Type: Review

References (60)

1. P.J. Barnes Small airways in COPD N Engl J Med 350 26 2004 2635-2637
2. D. Mapel J.C. Chen D. George R.J. Halbert The cost of chronic obstructive pulmonary disease and its effects on managed care Manag Care Interface 17 4 2004 61-66
3. S.I. Rennard Looking at the patient-approaching the problem of COPD N Engl J Med 350 10 2004 965-966
4. E.R. Sutherland R.M. Cherniack Management of chronic obstructive pulmonary disease N Engl J Med 350 26 2004 2689-2697
5. S.R. Rutgers W. Timens H.F. Kauffman D.S. Postma Markers of active airway inflammation and remodelling in chronic obstructive pulmonary disease Clin Exp Allergy 31 2 2001 193-205
6. J.M. Anto P. Vermeire J. Vestbo J. Sunyer Epidemiology of chronic obstructive pulmonary disease Eur Respir J 17 5 2001 982-994
7. L.M. Fabbri S.S. Kurd GOLD Scientific Committee. Global strategy for the diagnosis, management and prevention of COPD: 2003 update Eur Respir J 22 1 2003 1-2
8. R.A. Pauwels A.S. Buist P. Ma C.R. Jenkins S.S. Hurd Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary Am J Respir Crit Care Med 163 5 2001 1256-1276
9. G.L. Snider Chronic obstructive pulmonary disease: A definition and implications of structural determinants of airflow obstruction for epidemiology Am Rev Respir Dis 140 3 Pt 2 1989 S3-S8
10. R.A. Maxfield New and emerging minimally invasive techniques for lung volume reduction Chest 125 2 2004 777-783
11. J.K. Berry C. Baum Reversal of chronic obstructive pulmonary disease-associated weight loss: Are there pharmacological treatment options? Drugs 64 10 2004 1041-1052
12. W.Q. Gan S.F. Man A. Senthilselvan D.D. Sin Association between chronic obstructive pulmonary disease and systemic inflammation: A systematic review and a meta-analysis Thorax 59 7 2004 574-580
13. C. Fehrenbach NICE guidelines for chronic obstructive pulmonary disease - a review Nurs Times 100 24 2004 48-51
14. P.J. Barnes New treatments for COPD Nat Rev Drug Discov 1 6 2002 437-446
15. K.A. Stringer B.M. Freed J.S. Dunn S. Sayers D.L. Gustafson S.C. Flores Particulate phase cigarette smoke increases MnSOD, NQO1, and CINC-1 in rat lungs Free Radic Biol Med 37 10 2004 1527-1533
16. M. Saetta Airway inflammation in chronic obstructive pulmonary disease Am J Respir Crit Care Med 160 5 Pt 2 1999 Nov S17-S20
17. J.C. Hogg F. Chu S. Utokaparch R. Woods W.M. Elliott L. Buzatu et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease N Engl J Med 350 26 2004 2645-2653
18. G. Turato R. Zuin M. Miniati S. Baraldo F. Rea B. Beghe et al. Airway inflammation in severe chronic obstructive pulmonary disease: relationship with lung function and radiologic emphysema Am J Respir Crit Care Med 166 1 2002 105-110
19. B.G. Cosio L. Tsaprouni K. Ito E. Jazrawi I.M. Adcock P.J. Barnes Theophylline restores histone deacetylase activity and steroid responses in COPD macrophages J Exp Med 200 5 2004 689-695
20. S. Baraldo G. Turato C. Badin E. Bazzan B. Beghe R. Zuin et al. Neutrophilic infiltration within the airway smooth muscle in patients with COPD Thorax 59 4 2004 Apr 308-312
21. V.M. Keatings P.D. Collins D.M. Scott P.J. Barnes Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma Am J Respir Crit Care Med 153 2 1996 530-534
22. R. Finkelstein R.S. Fraser H. Ghezzo M.G. Cosio Alveolar inflammation and its relation to emphysema in smokers Am J Respir Crit Care Med 152 5 Pt 1 1995 1666-1672
23. G.M. Turino The origins of a concept: The protease-antiprotease imbalance hypothesis Chest 122 3 2002 1058-1060
24. W. Macnee I. Rahman Oxidants and antioxidants as therapeutic targets in chronic obstructive pulmonary disease Am J Respir Crit Care Med 160 5 Pt 2 1999 S58-S65
25. I. Rahman W. MacNee Lung glutathione and oxidative stress: Implications in cigarette smoke-induced airway disease Am J Physiol 277 6 Pt 1 1999 Dec L1067-L1088
26. M. Daheshia Therapeutic inhibition of matrix metalloproteinases for the treatment of chronic obstructive pulmonary disease (COPD) Curr Med Res Opin 21 4 2005 587-594
27. G.A. Finlay K.J. Russell K.J. McMahon E.M. D'arcy J.B. Masterson M.X. Fitzgerald et al. Elevated levels of matrix metalloproteinases in bronchoalveolar lavage fluid of emphysematous patients Thorax 52 6 1997 502-506
28. S. Lim N. Roche B.G. Oliver W. Mattos P.J. Barnes K.F. Chung Balance of matrix metalloprotease-9 and tissue inhibitor of metalloprotease-1 from alveolar macrophages in cigarette smokers. Regulation by interleukin-10 Am J Respir Crit Care Med 162 4 Pt 1 2000 1355-1360
29. L. Segura-Valdez A. Pardo M. Gaxiola B.D. Uhal C. Becerril M. Selman Upregulation of gelatinases A and B, collagenases 1 and 2, and increased parenchymal cell death in COPD Chest 117 3 2000 684-694
30. S. Molet C. Belleguic H. Lena N. Germain C.P. Bertrand S.D. Shapiro et al. Increase in macrophage elastase (MMP-12) in lungs from patients with chronic obstructive pulmonary disease Inflamm Res 54 2005 31-36
31. S. Kim J.A. Nadel Role of neutrophils in mucus hypersecretion in COPD and implications for therapy Treat Respir Med 3 3 2004 147-159
32. R. Puljic A. Pahl Smoke induced changes in epithelial cell gene expression: Development of an in vitro model for COPD ALTEX 21 1 2004 3-7
33. C. Beisswenger J. Platz C. Seifart C. Vogelmeier R. Bals Exposure of differentiated airway epithelial cells to volatile smoke in vitro Respiration 71 4 2004 402-409
34. S. Fuke T. Betsuyaku Y. Nasuhara T. Morikawa H. Katoh M. Nishimura Chemokines in bronchiolar epithelium in the development of chronic obstructive pulmonary disease Am J Respir Cell Mol Biol 31 4 2004 405-412
35. M. Saetta S. Baraldo L. Corbino G. Turato F. Braccioni F. Rea et al. CD8+ve cells in the lungs of smokers with chronic obstructive pulmonary disease Am J Respir Crit Care Med 160 2 1999 Aug 711-717
36. M. Saetta S. Baraldo G. Turato B. Beghe G.L. Casoni C.M. Bellettato et al. Increased proportion of CD8+ T-lymphocytes in the paratracheal lymph nodes of smokers with mild COPD Sarcoidosis Vase Diffuse Lung Dis 20 1 2003 28-32
37. Grumelli S, Cony DB, Song LZ, Song L, Green L, Huh J, et al. An immune basis for lung parenchymal destruction in chronic obstructive pulmonary disease and emphysema. PLoS Med 2004;1(1):e8.
38. M. Saetta G. Turato P. Maestrelli C.E. Mapp L.M. Fabbri Cellular and structural bases of chronic obstructive pulmonary disease Am J Respir Crit Care Med 163 6 2001 1304-1309
39. D. Miotto M.P. Ruggieri P. Boschetto G. Cavallesco A. Papi I. Bononi et al. Interleukin-13 and -4 expression in the central airways of smokers with chronic bronchitis Eur Respir J 22 4 2003 602-608
40. R. Rodriguez-Roisin Toward a consensus definition for COPD exacerbations Chest 117 5 Suppl. 2 2000 398S-401S
41. S. Sethi N. Evans B.J. Grant T.F. Murphy New strains of bacteria and exacerbations of chronic obstructive pulmonary disease N Engl J Med 347 7 2002 465-471
42. G. Rohde A. Wiethege I. Borg M. Kauth T.T. Bauer A. Gillissen et al. Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalisation: A case-control study Thorax 58 1 2003 37-42
43. P. Wongsurakiat K.N. Maranetra C. Wasi U. Kositanont W. Dejsomritrutai S. Charoenratanakul Acute respiratory illness in patients with COPD and the effectiveness of influenza vaccination: A randomized controlled study Chest 125 6 2004 Jun 2011-2020
44. S. Sethi New developments in the pathogenesis of acute exacerbations of chronic obstructive pulmonary disease Curr Opin Infect Dis 17 2 2004 113-119
45. S. Spencer P.M. Calverley P.S. Burge P.W. Jones Impact of preventing exacerbations on deterioration of health status in COPD Eur Respir J 23 5 2004 698-702
46. M. Saetta A. Di Stefano P. Maestrelli G. Turato M.P. Ruggieri A. Roggeri et al. Airway eosinophilia in chronic bronchitis during exacerbations Am J Respir Crit Care Med 150 6 Pt 1 1994 Dec 1646-1652
47. M. Saetta A. Di Stefano P. Maestrelli G. Turato C.E. Mapp M. Pieno et al. Airway eosinophilia and expression of interleukin-5 protein in asthma and in exacerbations of chronic bronchitis Clin Exp Allergy 26 7 1996 766-774
48. J. Zhu S. Majumdar Y. Qiu T. Ansari A. Oliva J.C. Kips et al. Interleukin-4 and interleukin-5 gene expression and inflammation in the mucus-secreting glands and subepithelial tissue of smokers with chronic bronchitis. Lack of relationship with CD8(+) cells Am J Respir Crit Care Med 164 12 2001 Dec 2220-2228
49. D.L. DeMeo E.K. Silverman Alpha1-antitrypsin deficiency. 2: Genetic aspects of alpha(1)-antitrypsin deficiency: Phenotypes and genetic modifiers of emphysema risk Thorax 59 3 2004 259-264
50. J.C. Celedon C. Lange B.A. Raby A.A. Litonjua L.J. Palmer D.L. DeMeo et al. The transforming growth factor-beta1(TGFB1) gene is associated with chronic obstructive pulmonary disease (COPD) Hum Mol Genet 13 15 2004 Aug 1 1649-1656
51. L. Joos COPD and genetics-what's new? Swiss Med Wkly 134 31-32 2004 437-439
52. X. Xu B. Rijcken J.P. Schouten S.T. Weiss Airways responsiveness and development and remission of chronic respiratory symptoms in adults Lancet 350 9089 1997 1431-1434
53. G.E. Silva D.L. Sherrill S. Guerra R.A. Barbee Asthma as a risk factor for COPD in a longitudinal study Chest 126 1 2004 59-65
54. N.G. Orie Correlations of emphysema and asthmatic constitution Acta Allergol 16 1961 407-409
55. M.H. Gotfried Macrolides for the treatment of chronic sinusitis, asthma, and COPD Chest 125 2 Suppl 2004 Feb 52S-60S
56. L.M. Fabbri M. Romagnoli L. Corbetta G. Casoni K. Busljetic G. Turato et al. Differences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease Am J Respir Crit Care Med 167 3 2003 Feb 1 418-424
57. A.B. Kay T cells, cytokines and asthma J R Coll Physicians Lond 28 4 1994 325-331
58. M. Albers T. Schermer G. van den Boom R. Akkermans C. van Schayck C. van Herwaarden et al. Efficacy of inhaled steroids in undiagnosed subjects at high risk for COPD: Results of the detection, intervention, and monitoring of COPD and asthma program Chest 126 6 2004 Dec 1815-1824
59. A. Spira J. Beane V. Shah G. Liu F. Schembri X. Yang et al. Effects of cigarette smoke on the human airway epithelial cell transcriptome Proc Natl Acad Sci U S A 101 27 2004 10143-10148
60. K. Ito M. Ito W.M. Elliott B. Cosio G. Caramori O.M. Kon et al. Decreased histone deacetylase activity in chronic obstructive pulmonary disease N Engl J Med 352 19 2005 1967-1976